These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia. Sekine M, Takami H. Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321 [Abstract] [Full Text] [Related]
10. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors. Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E. Clin Cancer Res; 2005 Jun 01; 11(11):4198-203. PubMed ID: 15930357 [Abstract] [Full Text] [Related]
11. Hypercalcemia of malignancy: diagnosis and therapy. Fetchick DA, Mundy GR. Compr Ther; 1986 Aug 01; 12(8):27-32. PubMed ID: 2943551 [Abstract] [Full Text] [Related]
16. Hypercalcemia and bone resorption in malignancy. Walls J, Bundred N, Howell A. Clin Orthop Relat Res; 1995 Mar 01; (312):51-63. PubMed ID: 7634618 [Abstract] [Full Text] [Related]
17. [Update on paraneoplastic hypercalcemia. Our experience in the treatment of hypercalcemic states of patients with advanced breast carcinoma]. Grottolo A, Ferrari V, Lazzari R, Mariano MR, Zambruni A, Zaniboni A. Minerva Med; 1988 Jul 01; 79(7):527-31. PubMed ID: 3405454 [Abstract] [Full Text] [Related]